The recently discovered non-mevalonate biosynthetic route to isoprenoid precursors is an essential metabolic pathway in plants, apicomplexan parasites, and many species of bacteria. The pathway relies on eight enzymes exploiting different cofactors and metal ions. Structural and mechanistic data now exist for most components of the pathway though there remain some gaps in our knowledge. The individual enzymes represent new, validated targets for broad spectrum antimicrobial drug and herbicide development. Detailed knowledge of the pathway may also be exploited to genetically modify microorganisms and plants to produce compounds of agricultural and medical interest.
Isopentenyl pyrophosphate (IPP)2 and dimethylallyl pyrophosphate (DMAPP) are the universal precursors of natural products called isoprenoids. This large family, in excess of 35,000 distinct compounds, includes molecules such as sterols, dolichols, triterpenes, ubiquinone, components of macromolecules such as prenyl groups, and isopentenylated tRNAs (1-3). The diverse chemical properties of isoprenoids are exploited in varied and important biological functions including electron transport, hormone-based signaling, the regulation of transcription and post-translational processes, meiosis, apoptosis, glycoprotein biosynthesis, and protein degradation. In addition, isoprenoids are structural components of cell and organelle membranes.Two biosynthetic routes to IPP and DMAPP have evolved. For many years it was assumed that the mevalonate (MVA) pathway was the sole route to IPP and DMAPP. This pathway uses seven enzymes to supply the precursors in most eukaryotes (all mammals), archaea, a few eubacteria, the cytosol and mitochondria of plants, fungi, and Trypanosoma and Leishmania (4). This pathway starts with production of acetoacetyl-CoA from two molecules of acetyl-CoA in a reaction catalyzed by thiolase. A third acetyl-CoA is then condensed with acetoacetyl-CoA to form 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) by HMG-CoA synthase. The NADPH-dependent HMG-CoA reductase then converts the CoA derivative to (R)-MVA. Next, in ATP-dependent steps, (R)-MVA is phosphorylated to (R)-MVA 5-diphosphate sequentially by mevalonate kinase and diphosphomevalonate kinase. The diphosphate is subsequently decarboxylated by mevalonate diphosphate decarboxylase to yield a pool of IPP. An IPP isomerase then produces DMAPP from some of the IPP. A wealth of data are available on the constituents of the MVA pathway in large part because of its relevance for human health. The MVA pathway leads to the biosynthesis of cholesterol, and inhibition of HMG-CoA reductase by statins controls production of the sterol with benefits for lowering blood pressure, the treatment of cardiovascular disease, and inflammatory processes (5).The mevalonate-independent pathway was discovered only recently (6 -8). This pathway is called the non-mevalonate route or alternatively, the 1-deoxy-D-xylulose-5-phosphate (DOXP) or 2C-methyl-D-erythritol-4-phosphate (MEP) pathway. This pathway occurs in plant ...